Peter R. Twentyman

Monoclonal‐antibody‐defined human lung tumour cell‐surface antigens

N. Bleehen, J. Stewart, P. Twentyman, 1985, International journal of cancer.

Intermittent exposure to doxorubicin in vitro selects for multifactorial non‐P‐glycoprotein‐associated multidrug resistance in RPMI 8226 human myeloma cells

M. Lehnert, E. Schneider, R. Scheper, 1997, British journal of haematology.

A new mouse tumor model system (RIF-1) for comparison of end-point studies.

J. Gray, P. Twentyman, R. Kallman, 1980, Journal of the National Cancer Institute.